-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Former GSK executive Stephen Pyke will lead the implementation and development of Jingding Pharmaceutical’s clinical data and digital strategy to better utilize data insights to support Jingding Pharmaceutical’s “patient-centric” strategic focus
Shanghai, October 12, 2021/PRNewswire/ - Parexel, a leading multinational clinical research organization (CRO) dedicated to the development and delivery of innovative therapies to improve human health, recently announced the appointment of Stephen Pyke is the executive vice president of clinical data and digital services
Dr.
Before joining Jing Ding Pharmaceutical, Pyke worked at GlaxoSmithKline as a senior vice president and head of digital data analysis and development
The new clinical data and digital service team integrates the existing functions of Jingding Medicine, including scientific data organization, global data operation, real-world evidence and scientific data technology
During the COVID-19 pandemic, Jingding Pharmaceutical found that it is becoming more and more important to listen to the voices of patients and fully understand the needs of patients, whether in traditional randomized controlled clinical trials or in real-world studies to collect data
About Jingding Pharmaceutical
Jing Ding Pharmaceutical is committed to supporting the development of innovative drugs to improve the health of patients
Source: Jing Ding Pharmaceutical